Pharmaceutical Breakthroughs and Retail Resilience

This chapter explores a newly approved memory loss drug from Eli Lilly and examines its implications in the competitive pharmaceutical market. It further analyzes the strong performance of TJX amid fluctuating stock prices and the effects of tariffs, emphasizing positive revenue trends and investor interest.